What are the recommended treatments for Lyme disease in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Recommendations for Lyme Disease in Pediatric Patients

For pediatric patients with Lyme disease, amoxicillin is the preferred first-line treatment for children under 8 years of age, while doxycycline is recommended for children 8 years and older. 1

First-Line Treatment Options by Age

Children Under 8 Years

  • Amoxicillin: 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) for 14 days 1, 2
  • Cefuroxime axetil: 30 mg/kg/day in 2 divided doses (maximum 500 mg per dose) for 14 days as an alternative 1, 3
  • Macrolides (e.g., azithromycin): Only if patient cannot tolerate first-line agents, as they are less effective 3, 1

Children 8 Years and Older

  • Doxycycline: 4 mg/kg/day in 2 divided doses (maximum 100 mg per dose) for 10-14 days 1, 4
  • Amoxicillin or cefuroxime axetil at doses listed above are alternatives 3, 1

Treatment by Clinical Manifestation

Early Localized Disease (Erythema Migrans)

  • Oral antibiotics for 14 days (10 days if using doxycycline) 1, 5
  • Most patients respond promptly and completely to appropriate therapy 1, 3

Early Disseminated Disease

  • For isolated facial nerve palsy without meningitis: oral therapy as above 3, 5
  • For meningitis or other neurological involvement: parenteral therapy with ceftriaxone 50-75 mg/kg/day IV once daily (maximum 2g) for 14 days 1, 3
  • Recent research suggests oral doxycycline may be effective for Lyme meningitis in children, though parenteral therapy remains the standard recommendation 6

Lyme Arthritis

  • Amoxicillin or doxycycline (age-appropriate) for 28 days 3
  • For persistent arthritis after initial therapy: second course of oral antibiotics or 2-4 weeks of IV ceftriaxone 3, 7
  • For antibiotic-refractory arthritis: NSAIDs, intra-articular corticosteroids, or DMARDs may be needed (consult rheumatology) 7, 3

Important Considerations

Medication Administration

  • Doxycycline should be taken with 8 ounces of fluid and with food to reduce esophageal irritation and gastrointestinal intolerance 1, 4
  • Patients on doxycycline should avoid sun exposure due to photosensitivity risk 1
  • Amoxicillin should be taken at the start of a meal to minimize gastrointestinal intolerance 2

Treatment Duration

  • Standard duration for early Lyme disease: 14 days for amoxicillin or cefuroxime; 10 days for doxycycline 1
  • For Lyme arthritis: 28 days of oral therapy 3
  • For neurological manifestations: 14 days of parenteral therapy 1, 3

Monitoring and Follow-up

  • Most patients respond well to appropriate therapy, but <10% may not respond as evidenced by persistent clinical manifestations 3, 1
  • Patients who are more systemically ill at diagnosis may take longer to have a complete response 3
  • For Lyme arthritis, resolution may take several months after antibiotic completion 7, 3

Common Pitfalls to Avoid

  • Using first-generation cephalosporins like cephalexin, which are ineffective against B. burgdorferi 1, 3
  • Prescribing fluoroquinolones, carbapenems, or other antibiotics not recommended for Lyme disease 1, 3
  • Multiple, repeated, or prolonged courses of antibiotics beyond recommended durations, which lack supporting data and may cause harm 3, 1
  • Using amoxicillin with probenecid in patients with neurologic symptoms, as probenecid may impair penetration of β-lactam antibiotics into brain parenchyma 3
  • Assuming that persistent symptoms after appropriate treatment always require additional antibiotics; some may represent post-Lyme disease syndrome or other conditions 5, 7

References

Guideline

Treatment for Children with Borrelia burgdorferi (Lyme Disease)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral Management for Pediatric Lyme Meningitis.

Journal of the Pediatric Infectious Diseases Society, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.